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It has recently been demonstrated that certain strains of mice characterized by a 
low incidence of spontaneous lymphoma produce significant levels of natural antibody 
specific  for  routine  leukemia  virus  (MuLV) ~ (1-3).  A  radioimmune  precipitation 
assay utilizing  3H-labeled AKR leukemia virus (2) was used to show an age-associated 
modulation of the levels of this autogenous humoral immune response to endogenous 
MuLV. Virus-precipitating antibody levels increased  as the mice developed immuno- 
logic competence and then decreased as a function of senescence.  The specificity  of 
this natural antibody for MuLV envelope antigens was demonstrated by immuno- 
electron microscopy (3),  and was also  associated with  the chronic development of 
glomerulonephritis (1, 3). Furthermore, in a population of RFM mice we have shown 
an inverse correlation between spontaneous lymphoid neoplasia and the severity of 
glomerulonephritis, which has been demonstrated in part to be caused by deposition 
of MuLV immune complexes (1). These data provide a basis for the consideration of 
host  immunologic mechanisms in  the  control  of  endogenous virus  burden  and  of 
leukemogenesis. 
Additional evidence for the significance of autogenous immunity to leukemia 
virus is provided by the fact that the Rgv-1 locus, which  causes resistance to 
leukemogenesis induced by Gross-passaged A virus in neonatal  mice, may be 
closely associated with or identical to the Ir-i gene, which determines immune 
responsiveness to certain antigens  (4), and thus may function in immune con- 
trol of MuLV  antigens  (4,  5).  The possibility must be considered  that while 
the  viral genome is ubiquitous  in mouse cells  and  can be activated,  and  al- 
though  cell  susceptibility  to  virus  infection  is  controlled  by  genetic  factors 
(Fvl, Fv2, etc.), an additional level of immunological control may be sginificant 
in preventing the intercellular spread of endogenous leukemia virus, which may 
play a major role in leukemogenesis. Therefore, the immunological factors that 
may limit endogenous virus burden should be characterized. 
* Research supported jointly by the Virus Cancer Program of the National Cancer Insti- 
tute and by the U. S. Atomic Energy Commission under contract with the Union Carbide 
Corporation. 
1  Abbreviations used in this paper: MuLV, routine leukemia virus; SPF, specific pathogen- 
free; TNE, 0.05 M Tris (pH 7.5)-0.1 M NaCI-1 mM ethylenediaminetetraacetate. 
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Considerable  research  has  been  directed  at  identifying  and  isolating  the 
polypeptide components of mammalian  C-type tumor viruses, as well as classi- 
fying serological reactivities against viral components.  Such studies have used 
heterologous  antisera  against  purified  viral  components  (6,  7)  or  against  dis- 
rupted virus (8),  or more commonly have used antisera prepared  from tumor- 
bearing animals in heterologous systems (9,  10). In the present studies we have 
attempted  to identify the viral components  that  are specifically recognized by 
natural autogenous immune sera. 
Materials and Methods 
Animals.--Male  BALB/c and  B6C3Fx  (C57BL/6  9  X  C3H/Anf  o  ~)  of  various ages 
were used.  C57BL/6 female parents and  C3I-I/Anf male parents of the B6C3Fz were also 
used; these mice were approximately 6 mo of age and were retired breeders of their respective 
inbred colonies.  All mice were specific pathogen-free (SPF). 
Test Sera.--Blood was collected by orbital bleeding or cardiac puncture and  allowed to 
clot at room temperature, and serum was separated by centrifugation. Samples of serum were 
frozen at  --70°C until use.  (Samples of serum were never thawed  more than  once.) 
Anti-K36 test serum was prepared by immunizing C57BL/6 males with K36 cells derived 
and passaged in AKR mice. The immunization regimen consisted of an initial subcutaneous 
injection of 2 X  10  T cells,  followed by four intraperitoneal injections of 2 X  10 T cells every 
2 wk.  Mice were bled 10--14 days after the last immunization, and serum was prepared as 
described above. The various normal and  test sera were tested for antibody to MuLV en- 
velope antigen by radioimmune precipitation assay as described below and by immunoelec- 
tron microscopy as described previously (3). 
Preparation of Radioactively Labeled Virus.--[SH]leucine-labeied  virus was prepared as pre- 
viously described  (2).  [SH]glueosamine-labeled  virus was  prepared  similarly,  using Eagle's 
minimal essential medium that was supplemented with 2 mM glutamine and  10% fetal calf 
serum and contained 50 #Ci/ml of D-glueosamine-[6-SH]hydrochlorine  (12.6  Ci/mmol; Amer- 
sham/Searle Corp., Arlington Heights, Ill.). 
Radioimmune  Precipitation  Assays Against  Disrupted  Virus.--Intact  [SH]leucine-labeled 
AKR virus was purified and  recovered from isopycnic sucrose gradients as previously de- 
scribed  (2).  The virus was diluted  fivefold with TNE buffer  (0.05  M  Tris, pH  7.5-0.1  M 
NaCI-1 mM ethylenediaminetetraacetate)  and concentrated by pelleting at 4°C in a  Beck- 
man 65 rotor (Beckman Instruments, Inc., Spinco Div., Palo Alto, Calif.) at 40,000  rpm for 
2 h. The viral pellet was resuspended in a  minimal volume of TNE and centrifuged at 2,000 
rpm for 20 rain in an International PR-2 centrifuge  (International Equipment Co., Needham 
Heights, Mass.). Aliquots of the clarified virus were frozen at -70°C until use. Immediately 
before radioimmune precipitation assays, aliquots of virus were mixed with an equal volume 
of disruption buffer  (1.2 M  KCI-I% Triton  X-100-0.03  M/3-mercaptoethanol-0.1  M  Tris, 
pH 7.5). The virus was disrupted at 4°C for 1 h. The extract was then either diluted 10-fold 
with distilled water or extracted five times at 25°C with 3 vol of ether; residual ether was 
removed by passing nitrogen gas over the sample. In either case the extracts were centrifuged 
at 2,000 rpm for 20 min at 4°C in an International PR-2 centrifuge immediately before the 
assay. The two techniques gave essentially identical results. 
For titration assays, the test serum (0.1 ml) was twofold serially diluted in TNE, and the 
antigen (~60,000 cpm) in 0.05 mlwas added. The mixture was incubated at 37°C for 3 h and 
at 4°C for 14 h. The samples were then diluted with 0.9 ml of TNE and 0.2  ml of a poly- 
specific  antiglobulin  (Cappel  rabbit  antimouse  gamma-globulin or  Cappel  goat  antirabbit 
gamma-globulin) was added. The precipitates were allowed to form at 37°C for 2 h  and at 
4°C for 3 h. The precipitates were collected by centrifugation at 2,000 rpm for 15 min~in an 
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activity. The precipitates were washed five times with 2-ml aliquots of TNE, resuspended in 
1 ml of distilled water, and prepared for scintillation counting. All samples were counted in 
10 ml of Aquasol (New England Nuclear, Boston, Mass.)  in a Nuclear-Chicago scintillation 
counter (Nuclear-Chicago Corp., Des Plaines, Ill.). Precipitation is expressed  as the percent- 
age of counts in the precipitate relative to the combined counts in the precipitate and the 
first supernate. The radioimmune precipitation titer is defined as the serum dilution at which 
50%  of  the  maximum radioactivity is  precipitated. 
To prepare immune precipitates for polyacrylamide gel electrophoresis,  0.05 ml of serum 
was added to 1.0-2.0 X  105 cpm of antigen and reacted as above. The immune complexes 
were precipitated as above with 0.1 ml of antiglobulin, and the precipitates were  collected 
and washed four times with TNE as above. After the last wash the precipitates were resus- 
pended in 1 ml of TNE and overlaid on 1.0 ml of a 25% sucrose solution containing  TNE and 
0.5% deoxycholate.  The precipitates were pelleted at 2,000 rpm for 20 rain in an Interna- 
tional PR-2 centrifuge (International Equipment Co.) and finally  resuspended in 0.05 ml of a 
solution containing 1% SDS, 1%/~-mercaptoethanol, and 0.01 M sodium phosphate buffer at 
pH 7.4. The mixture was incubated at 60°C for 1 h and at 37°C for  14 h to dissolve the pre- 
cipitate before electrophoresis. 
Radidmmune  Precipitation Assays Against  Intact Virus.--Titration assays against intact 
virus were  performed as previously described  (2). To determine the antigens recognized  in 
the precipitation of intact virus, the virus was precipitated at a  1:8 dilution of test serum. 
The immune precipitate was resuspended in 0.5 ml of TNE, and 0.5 ml of disruption buffer 
was added. The mixture was incubated at 4°C for 1 h, and the immune precipitate was col- 
lected, washed, and prepared for gel electrophoresis  as described above. 
SDS-Polyacrylamide  Gel  Electrophoresis.--SDS-polyacrylamide  gel  electrophoresis  was 
performed by the method of Weber and Osborn (11). Bromphenol blue was used as a refer- 
ence standard to determine relative mobilities and was generally allowed  to migrate 8 cm. 
Gels of standard protein samples to calibrate the system were stained with Coomassie  blue 
(ICI America Inc., Stamford,  Conn.). Radioactivity profiles  of the gels were obtained by 
sectioning the gels into 1-mm sections with a Mickel gel slicer, dissolving individual sections 
in 0.2 ml of 30o/o hydrogen peroxide at 75°C overnight, and determining radioactivity in a 
liquid scintillation counter after the addition of 10 ml of Aquasol (New England Nuclear). 
gs Antilerum.--The gs-1 antigen from Rauscher leukemia virus was purified from deoxy- 
cholate-disrupted virus by G-150 gel filtration and fractional ethanol precipitation (J. N. Ihle 
and F. T. Kenney, unpublished results). Antiserum was prepared by immunizing  New Zealand 
white rabbits with 0.3 mg of gs antigen in Freund's complete adjuvant injected intramuscu- 
larly, followed by intravenous injection of 0.3 mg of gs antigen 2 wk later. Serum samples 
were collected by ear bleeding. 
RESULTS 
Standard  1.5  yr  B6C3F1  serum  titrated  against  [3H]leucine-labeled,  intact 
MuLV  precipitated  90%  of the label at high  serum concentration and had  a 
radioimmune precipitation titer of 320 (Fig. 1). However, when the same serum 
was reacted with solubilized proteins from virus disrupted with Triton and high 
salt, considerably less of the radioactivity was precipitated and the concentra- 
tion dependence for precipitation yielded a more complex curve. At high serum 
concentration approximately 8 %  of the radioactivity in the solubilized prepa- 
rations was precipitated. This percentage dropped to  1.5 %  at  a  1:80 dilution, 
remained above  1%  to  a  dilution of  1:640,  and then dropped  again at higher 
dilutions. In  contrast  to  these  results,  a  titration  of  antiserum  prepared  in 
rabbits against gs antigen gave a  typical immune precipitation curve with the IHLE~ HANNA~ ROBERSON,  AND  KENNEY  1571 
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FIO.  1. Titration of standard  B6C3F1 serum with intact  [3H]leucine-labeled  AKR virus 
(@) and with a preparation of Triton-disrupted AKR virus (A). Titration of rabbit anti-gs 
serum  (O)  and  normal  rabbit  serum  (A)  with Triton-disrupted  AKR virus.  Titration  of 
standard B6C3F1 serum with Triton-disrupted [3H]glucosamine-labeled  AKR virus (l). 
same solubilized viral extract. Normal rabbit serum titrated against the same 
extract failed to precipitate any radioactivity. These data suggest that only a 
small fraction of the solubilized viral  proteins is recognized by the B6C3F2 
serum. Also,  the complex nature of the titration curve suggests that two or 
more components are probably involved. 
To determine which viral proteins were being recognized and precipitated by 
B6C3F, serum, immune precipitates were examined by SDS-polyacrylamide gel 
electrophoresis. Tl~e gel profile of an immune precipitate obtained when B6C3F1 
serum was reacted with disrupted virus is shown in Fig. 2 A. Three viral protein 
peaks  are  discernible,  which  migrate  during  electrophoresis  with  mobilities 
(relative to bromphenol blue) corresponding to mol wt of approximately 68,000, 
43,000, and 17,000, based on the standard curve shown in Fig. 3. In Fig. 2 B the 
gel profile of the total extract of viral proteins is shown for comparison. It is 
apparent that normal B6C3F1 serum reacts only with minor components of the 
virus proteins. 
To ensure that the components observed were being specifically precipitated 
by the B6C3Fs serum, reactions of disrupted virus with two control sera were 
examined. In Fig. 4 is shown the gel profile of an immune precipitate of rabbit 
anti-gs serum reacted with disrupted virus.  As  expected, most of the radio- 
activity (85 %) migrates with an apparent mol wt of 31,000. Also shown in Fig. 
4 is the gel profile of normal rabbit serum reacted with disrupted virus, which 
yields no discernible peaks of radioactivity. These data indicate that the pro- 
teins  observed  with  B6C3F1  immune precipitates  are  specific  and  reflect  a 
natural immunological reaction with these viral components. 
The above results indicate that normal B6C3F, serum reacts immunologically 1572  AUTOGENOUS  IMMUNITY  TO  RNA  TITJ~OR VIRUS 
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Fro.  2.  (A)  SDS-polyacrylamide gel electrophoresis profile of  an immune precipitate of 
B6C3F1 serum reacted with a Triton-ether extract of AKR virus. (B) Electrophorefic profile 
of the total Triton-ether extract.  Mobilities are plotted relative to the migration of brom- 
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FIG. 3.  Standard curve for determination of molecular weights by SDS-polyacrylamide 
gel electrophoresis.  Standards include lysozyme (14,300), chymotrypsinogen (25,700), glycer- 
aldehyde phosphate dehydrogenase (36,000), ovalbumin (43,000), and bovine serum albumin 
(68,000). Mobilities were determined relative to bromphenol blue. 
with specific viral components, but they do not show which of the antigens ob- 
served are responsible for precipitation of the intact virus in the radioimmune 
precipitation  assay.  To  resolve  this  question  we  reacted  intact  virus  with 
B6C3Fx serum as in a standard radioimmune precipitation assay. The immune 
precipitates, which contained 90 % of the initial radioactivity, were washed as 
described in the Materials and Methods. The immune precipitates were subse- 
quently treated with Triton and high salt to disrupt the virus and sotubilize 
the viral proteins. After disruption, the immune precipitates were again col- 
lected and washed as described above. In control experiments, when labeled 
virus was added in the presence of Triton and high salt to immune precipitates 
formed  in  the  absence  of  labeled  virus,  no  radioactivity was  precipitated. 
Furthermore, antigen-antibody complexes that formed initially were not dis- 
sociated. Therefore, under these conditions only immune precipitates formed 
upon reaction with the intact virus are preserved. These manipulations resulted 
in solubilization of approximately 95 %  of the initially precipitated radioac- 
tivity. The final immune precipitate was subsequently analyzed by gel electro- 
phoresis (Fig. 5). The three viral proteins seen initially (Fig. 2 A) are present, 
although the ratios of the 17,000 to the 68,000 and to the 43,000  mol wt com- 
ponents are somewhat decreased. This difference might reflect altered affinities 
to the respective antibodies for solubilized antigens, compared to antigens in 
their natural state.  Secondly. two additional components are observed with 
apparent mol wt of 19,000 and 15,000. These two peaks are occasionally present 
when B6C3F1  serum is reacted with disrupted virus but are more generally 1574  AUTOGENOUS  IMMUNITY  TO  RNA  TUMOR  VIRUS 
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FIG. 4.  SDS-polyacrylamide gel electrophoresis profile Of an immune precipitate of rabbit 
anti-gs serum (©) and normal rabbit serum (e) reacted against virus disrupted with Triton 
and ether. Mobilities are plotted relative to the migration of bromphenol blue. 
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FIG. 5. SDS-polyacrylamide gel electrophoresis profile of an immune precipitate remaining 
after Triton disruption of an immune complex between B6C3F1 serum and intact AKR virus 
(see text for details). Mobilities are plotted relative of bromphenol blue. 
detected as shoulders on the peak representing the 17,000 mol wt component, 
apparently due to a low natural titer against these two antigens,  as discussed 
below. These data  demonstrate  that  the antigens  recognized by  the B6C3F1 
serum in preparations of disrupted virus are also recognized in the intact virus, 
suggesting that they are viral envelope antigens. 
To identify further the viral components recognized in the autogenous  im- 
mune reaction, we utilized [3H]glucosamine-labeled  virus. In contrast to [SH]- IHLE,  HANNA, ROBERSON, AND  KENNEY  1575 
leucine-labeled virus, when B6C3FI serum is titered against disrupted pH]glu- 
cosamine-labeled virus (Fig. 1), approximately 40 % of the label is precipitated 
at high serum concentrations. The percentage of radioactivity subsequently 
drops and a plateau value is not evident. The lower titer of this serum against 
the pH]glucosamine-labeled viral proteins is a  result of the lower radioactive 
specific  activity of these preparations. When the immune precipitations were 
analyzed by SDS-polyacrylamide gels, the results shown in Fig. 6 were obtained. 
Two antigenic reactivities are  evident, with apparent mol wt of 68,000  and 
43,000, and presumably are the same antigens that were seen when pH]leucine 
was used. The results suggest that these two antigens are glycoproteins while 
the 17,000 tool wt antigen is not. When normal B6C3F1 serum was reacted with 
intact pH]glucosamine-labeled virus, the virus was precipitated and disrupted 
as above, and the immune complexes were analyzed by SDS-polyacrylamide gel 
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FIG. 6. SDS-polyacrylamide  gel electrophoresis  profile  of an immune  precipitate of B5C3F1 
serum reacted with Triton-disrupted, [3H]glucosamine-labeled  AKR virus. 
electrophoresis, profiles identical to that in Fig. 6  were obtained. This again 
suggests that these proteins are viral envelope antigens. 
We have previously reported that marked differences in age-associated levels 
of the autogenous immune response and mouse strain differences in the immune 
response  can be  detected by the radioimmune precipitation assay (2).  These 
differences could be due either to quantitative differences in the same antibodies 
or  to antibodies which recognize different viral  antigens.  The  age-associated 
differences in autogenous immunity of B6C3F1  serum were examined by gel 
electrophoresis of immune precipitates formed with 14-wk,  1-yr, and 2-yr sera. 
All of the profiles were identical to that shown in Fig. 2 A, indicating that any 
age-associated differences in  the  autogenous immune reaction  against intact 
virus probably involve quantitative differences against identical antigens. 
Sera from various strains of mice were examined by radioimmune precipita- 
tion (Fig. 7) and by electrophoresis (Fig. 8) to determine the consistency of the 
recognition of viral antigens by natural antibodies. The profile obtained with 
C57BL/6  serum  (Fig.  8  A)  is  qualitatively  similar  to  that  obtained  with 1576  AUTOGENOUS  IMMUNITY  TO  RNA  TUMOR  VIRUS 
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Fro. 7. Titration of various sera with intact, [SH]leucine-labeldd AKR virus. (O), C57BL/ 
6; (e), C57BL/6 enti-K36; (~), C3H/Anf; and (A), BALB/c. 
B6C3F1  serum  but  shows  additional  components with  mol wt of  19,000  and 
15,000.  A profile obtained with  1 yr BALB/c serum (not shown) was identical 
to that found with C57BL/6 serum. The reactivity of C3H serum (Fig. 8 B) is 
identical to that of C57BL/6 with respect to the antigens precipitated but differs 
quantitatively with respect to the ratio of the 68,000  and the  17,000  mol wt 
components.  When  B6C3F1  and  C3H  sera  were  compared  against  identical 
virus preparations, the amount of radioactivity in the 17,000 mol wt component 
was similar for both, indicating that the difference in reactivity is in the 68,000 
mol wt fraction. It may be that the C3H serum reacts with an additional antigen 
which fortuitously migrates in the same manner. 
We also examined C57BL/6 anti-K36 serum to determine whether immuni- 
zation against a  MuLV-producing tumor alters the autogenous immune reac- 
tion.  The  radioimmune  precipitation  titer  of  C57BL/6  anti-K36  serum  is 
significantly  higher  than  that  of  control  C57BL/6  serum  (Fig.  7),  but  gel 
electrophoresis of an immune precipitate results in an almost identical profile 
compared to the control serum (Fig. 8 C). 
DISCUSSION 
There is now considerable evidence  against the concept that mice are  immuno- 
logically  tolerant  to  endogenous  leukemia  virus.  Initially,  glomerular  lesions  ob- 
served in aged mice of certain strains, such as RFM and B6C3F1 (1, 3), NZB (12), 
and AKR (13, 14), were shown to be in part a result of chronic deposition of immune 
complexes between specific antibody and virus antigens. In some strains as much as 
70% of the antibody that is eluted from kidneys of aged mice may be specific for 
MuLV antigen (15), and intact C-type virus has been detected in these glomerular 
lesions  (16).  The specificity  of this antibody in  serum and kidney eluates and  the 
presence of free antibody specific for MuLV envelope antigens have more recently IHLE~  HANNA~ ROBERSON~ AND  KENNEY  1577 
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FIG.  8.  SDS-polyacrylamide gel electrophoresis profiles of immune precipitates of AKR 
virus disrupted with Triton and  ether and reacted against  C57BL/6 serum  (A),  C3H/Anf 
serum (B), and C57BL/6 anti-K36 serum (C). Mobilities are plotted relative to the migration 
of bromphenol blue. 
been demonstrated by immunoelectron microscopy (3). The subsequent development 
of a  radioimmune precipitation  assay  has  allowed further  demonstration  of the ex- 
istence of free antibodies against MuLV envelope antigens and has allowed a  quan- 
titative evaluation of the extent of autogenous  immunity as a  function  of age and 1578  AUTOGENOUS  IMMUNITY  TO  RNA  TUMOR  VIRUS 
strain (2). The studies presented here further explored  the autogenous immune reac- 
tion by attempting to identify viral proteins that are naturally antigenic. We have 
concentrated our studies on the B6C3F1 hybrid mouse strain, which has a mean sur- 
vival time of  -~884  days and  a  low  natural  incidence  of  thymic lymphoma (17); 
a similar hybrid from a reciprocal mating (C3H X  C57BL)F1 has a much lower Gross 
virus susceptibility than either parental strain, and this resistance has been geneti- 
cally associated with the Rgv-1 locus. 
The  immunological  reactions  we  have  observed  with  B6C3F1  serum  are 
primarily with viral antigens  having  approximate  mol wt  in  SDS-polyacryl- 
amide  gel  electrophoresis  of  68,000,  43,000,  and  17,000.  Furthermore,  the 
ability of the serum to react with these antigens in intact virus suggests that 
they are viral envelope antigens, and the observation that only the 68,000 and 
43,000 mol w t antigens are detected when [3H]glucosamine-labeled virus is used 
suggests that those two antigens are glycoproteins. The 68,000 tool wt antigen 
we have observed here may correspond to the viral envelope glycoprotein M2, 
which  has  an  approximate  mol  wt  of  70,000  by  gel  filtration  in  guanidine 
hydrochloride  (6,  7,  18)  and has been reported in Rauscher  MuLV to have a 
mol  wt  of  approximately 80,000  by  SDS-polyacrylamide gel  electrophoresis 
(19). 
The identity of the 43,000 mol wt glycoprotein is equivocal.  A minor glycoprotein 
fraction with  an apparent tool wt of approximately 42,000 has been reported  for 
Rauscher MuLV by SDS-polyacrylamide gel electrophoresis (19). A comparable frac- 
tion is not observed by gel filtration in guanidine hydrochloride (18), but a  100,000 
mol wt glycoprotein fraction is observed and has been termed M~. The M~ fraction 
appears to be an aggregate under these conditions and will partially dissociate upon 
subsequent SDS-polyacrylamide gel electrophoresis.  The products of this dissociation 
are thought to be a 43,000 mol wt glycoprotein and a glycolipid fraction (D. P. Bolog- 
nesi,  personal communication). In agreement with these observations, we have ob- 
served that SDS-polyacrylamide gel electrophoresis of [*H]glucosamine-labeled  virus 
results in a major peak with an apparent mol wt of 68,000 and a minor peak at 43,000, 
with considerable  radioactivity remaining at the origin of the gel. However, treatment 
of the virus with serum apparently facilitates solubilization  of this complex, and with 
our immune precipitates all of the radioactivity migrates into the gel and a substan- 
tial increase in the 43,000 mol wt component is evident. 
A ~ral envelope antigen with an apparent tool wt of 17,000  has not to our 
knowledge been previously reported.  The ability of antibodies  to bind to the 
antigen in intact virus suggests that it is an envelope antigen. However, since 
this antigen is not detected with [3H]glucosamine-labeled virus, it presumably 
is not a  glycoprotein. This antigen is routinely precipitated by serum from all 
normal strains of mice we have examined; thus it would be interesting to deter- 
mine whether  it exhibits  type-, group-, and interspecies-specific determinants 
similar to those of other viral antigens (7, 20, 21). 
Although these experiments indicate which  viral proteins are naturally antigenic, 
they do not indicate the quantitative differences in a particular serum for each antigen. IHLE,  HANNA,  ROBERSON,  AND  KENNEY  1579 
Such information will be obtainable when techniques are developed by which each 
antigen can be isolated and still maintain its natural antigenicity, and that knowledge 
should  help us to understand the role of the autogenous immune  response  in viral 
replication in vivo. Although suitable purified antigens are not now available, we have 
attempted to compare the titer of B6C3FI  serum  against the three components we 
have identified by quantitating on SDS-polyacrylamide  gels the amount of each anti- 
gen precipitated at various serum dilutions.  Preliminary results suggest that the M2 
reaction is predominant, and it appears to be responsible  for the radioimmune pre- 
cipitation titer against intact virus. The titer against the  17,000 mol wt antigen is 
somewhat  less, followed by a weak reaction against the MI component. 
The most important point to determine with respect to these results, is the 
efficacy of each reaction. The natural sera we have used in these experiments 
have only weak  and variable,  complement-independent neutralizing  activity 
against AKR or Moloney MuLV in tissue culture, as assayed by the XC plaque 
assay (3). The lack of a strong neutralizing activity of these sera could be due 
either to the limited sensitivity of the in vitro assay or to the ratio of noninfec- 
tious or infectious particles in the virus preparations. Lastly, the observation 
of an inverse relationship between the severity of glomerulonephritis, caused in 
part  by immune  complexes with  MuLV,  and  the  incidence of lymphoma in 
some mouse strains (1) suggests that a lack of in vitro neutralization may not 
preclude a functional immunological response in vivo. 
The experiments reported here were done with unfractionated serum. We are 
currently attempting  to classify each reaction in  terms of specific type(s)  of 
antibody. This point will be of particular interest in assessing the strain varia- 
tions in the autogenous immune response and may indicate whether qualitative 
as well as quantitative differences in reactivity to viral antigens determine the 
in vivo efficacy of the response. 
The immunological reactivity in terms of the viral antigens recognized ap- 
pears qualitatively consistent in all the mouse strains examined. All the natural 
sera examined react with the 68,000, 43,000, and 17,000 mol wt species. Anti- 
bodies that precipitate the 19,000 and 15,000 mol wt species are somewhat more 
variable; in the present studies, all natural sera except the B6C3FI appeared to 
react  with  these  proteins.  Of  considerable  interest  is  the  observation  that 
C57BL/6 anti-K36 antiserum, which enhances the antivirus titer in the radio- 
immune  precipitation  assay,  reacts  with  the  same  viral  components  as  sera 
from control animals, except for an additional reactivity at a tool wt of 35,000. 
This observation suggests that hyperimmunization only slightly modifies the 
existing immune response qualitatively but can significantly alter the response 
quantitatively. 
The observations reported here have been limited to the autogenous immune 
response to a single type of virus, a spontaneously activated MuLV from AKR 
cells.  This virus represents an N-tropic Gross-type MuLV. We are presently 
examining the autogenous immune reaction with regard to other viral isolates. 
In particular, it is necessary to determine whether the serological differences 1580  AUTOGENOUS  IMMUNITY  TO  RNA  TUMOR  VIRUS 
recognized by heterologous antisera correspond to differences in reactivifies in 
the autogenous immune reactions. 
SUMMARY 
The  viral antigenic determinants  recognized in an  autogenous  immune 
response in mice against  their  endogenous C-type virus  have been identified  by 
SDS-polyacrylamide gel  elcctrophoresis  of  immune precipitates  between various 
sera and H3-1abcled intact  or disrupted AKR  leukemia virus.  Normal B6C3FI 
[(C57BL/6 X  C3H/Anf)FI] serum reacts  with viral  envelope antigens having 
tool wt of approximately 68,000,  43,000, and 17,000.  In addition,  minor reac- 
tions  with viral  antigens  having tool  wts of approximately 19,000  and 15,000  are 
demonstrable. The 68,000 and 43,000 tool wt antigens can be labeled with 
[3H]glucosaminc and may correspond to the major viral  envelope antigens M2 
and MI, respectively. 
The antigens recognized by autogenous immune sera  do not differ  with re- 
spect  to age of the animal, nor are they significantly  different  in  sera  from vari- 
ous strains  of mice (BALB/c, C57BL/6, and C3H/Anf). These results  suggest 
that  the  agc-asociated  and strain  variations  in  the autogcnous immune response, 
as determined by radioimmune precipitation  assays against intact  virus,  are 
due to quantitative and  qualitative alterations of antibody  levels against 
common antigens. 
We thank  Dr. D. P. Bologncsi  for  his  helpful  consultations  regarding  this  work. 
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